Logo

2019 Vol.37, N°2 - Table of contents

March-April 2019

Title: March-April 2019

Purchase all articles

PageArticle - [Author(s)]PDFAbs.
Review

CER12208
2019,37,2
Pg. 0167-0178

One year in review 2018: psoriatic arthritis
E. Calabresi, S. Monti, G. Governato, L. Carli › Free to View
Rheumatology ArticleRheumatology Abstract
Full Papers

CER11160
2019,37,2
Pg. 0179-0185

Prevention of the progressive biochemical cartilage destruction under methotrexate therapy in early rheumatoid arthritis
P. Sewerin, A. Müller-Lutz, D. Abrar, S. Odendahl, M. Eichner, M. Schneider, B. Ostendorf, C. Schleich › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER11183
2019,37,2
Pg. 0186-0192

Reduced quality of life impacts knowledge and type of informed consent in rheumatoid arthritis patients.
V. Pascual-Ramos, I. Contreras-Yáñez, D. Ruiz, M. de la Luz Casas-Martínez
Rheumatology Article
Rheumatology Article
Rheumatology Abstract
 

CER11229
2019,37,2
Pg. 0193-0198

Validation of the Italian version of proposed GRAPPA flare questionnaire for patients with psoriatic arthritis
S. Scriffignano, F. Perrotta, A. De Socio, A. Altobelli, P. Sessa, R. Scrivo, G. Valesini, E. Lubrano
Rheumatology Article
Rheumatology Article
Rheumatology Abstract
 

CER11207
2019,37,2
Pg. 0199-0207

Clinical and quality of life improvements with golimumab or infliximab in a real-life ankylosing spondylitis population: the QUO-VADIS study
F. Van den Bosch, R. Flipo, J. Braun, N. Vastesaeger, S. Kachroo, M. Govoni
Rheumatology ArticleRheumatology Abstract
 

CER11199
2019,37,2
Pg. 0208-0214

Immunological signatures in saliva of systemic lupus erythematosus patients: influence of periodontal condition
S. Mendonça, J. Corrêa, A. Souza, D. Travassos, D. Calderaro, N. Rocha, É. Vieira, A. Teixeira, G. Ferreira, T. Silva › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER11118
2019,37,2
Pg. 0215-0221

Clinical and genetic characteristics of ankylosing spondylitis patients with peripheral arthritis at disease onset
J. Polo y La Borda, M. Szczypiorska, N. Bartolomé, J. Campos, B. Flores-Robles, J. Sanz, C. Fernández-Espartero, T. Clavaguera, R. Andrus, M. Artieda, D. Tejedor, A. Martínez, J. Mulero, C. Isasi, J. Andréu, A. Sánchez › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER11146
2019,37,2
Pg. 0222-0226

Association of a polymorphism of the Fcγ-receptor 2A (FCGR2A) gene with chronic periaortitis
F. Alberici, F. Bonatti, F. Maritati, M. Urban, G. Moroni, G. Emmi, A. Adorni, M. Reina, A. Vaglio, D. Martorana › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER11202
2019,37,2
Pg. 0227-0234

Efficacy and safety of certolizumab pegol in combination with methotrexate in methotrexate-inadequate responder Chinese patients with active rheumatoid arthritis: 24-week results from a randomised, double-blind, placebo-controlled phase 3 study
L. Bi, Y. Li, L. He, H. Xu, Z. Jiang, Y. Wang, X. Li, W. Wei, J. Gu, G. Wang, Z. Zhang, B. Zhou, Y. Liu, Z. Wu, H. Liu, D. He, Z. Lv, Z. Li, X. Zuo, L. Dong, H. Wu, H. Zhang, H. Chen, C. Bao, Z. Zhang, M. Zhang, H. Song, Y. Zheng, L. Jiang, X. Liu, M. Boehnlein, J. Dunkel, J. Shao, K. Harris, Z. Li › Free to View
Rheumatology Article
Rheumatology Article
Rheumatology Abstract
 

CER11310
2019,37,2
Pg. 0235-0241

Feasibility, safety and efficacy of exercise training in immune-mediated necrotising myopathies: a quasi-experimental prospective study
J. de Souza, D. de Oliveira, L. Perin, R. Misse, A. dos Santos, B. Gualano, A. de Sá Pinto, H. Roschel, F. Lima, S. Shinjo
Rheumatology ArticleRheumatology Abstract
 

CER11156
2019,37,2
Pg. 0242-0253

Associations between interleukin-10 gene polymorphisms and systemic lupus erythematosus risk: a meta-analysis with trial sequential analysis
Y. Yuan, X. Wang, L. Ren, Y. Kong, J. Bai, Y. Yan › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER11134
2019,37,2
Pg. 0254-0259

Clinical features and risk of recurrence of acute calcium pyrophosphate crystal arthritis
J. Lee, S. Hong, O. Kwon, B. Ghang, Y. Kim, C. Lee, B. Yoo
Rheumatology ArticleRheumatology Abstract
 

CER11119
2019,37,2
Pg. 0260-0269

Secukinumab provides rapid and persistent relief in pain and fatigue symptoms in patients with ankylosing spondylitis irrespective of baseline C-reactive protein levels or prior tumour necrosis factor inhibitor therapy: 2-year data from the MEASURE 2 stud
A. Deodhar, P. Conaghan, T. Kvien, V. Strand, B. Sherif, B. Porter, S. Jugl, K. Gandhi; on behalf of the MEASURE 2 study group
Rheumatology ArticleRheumatology Abstract
 

CER11150
2019,37,2
Pg. 0270-0278

Reciprocal interaction between macrophage migration inhibitory factor and interleukin-8 in gout
K. Kim, B. Kim, K. Lee, H. Kim, S. Lee, H. Kim
Rheumatology ArticleRheumatology Abstract
 

CER11295
2019,37,2
Pg. 0279-0285

Antineutrophil cytoplasmic antibody and/or antiglomerular basement membrane antibody associated crescentic glomerulonephritis in combination with IgG4-related tubulointerstitial nephritis
G. Wang, Y. Chen, H. Cheng, X. Xu, L. Sun, H. Dong
Rheumatology ArticleRheumatology Abstract
 

CER11255
2019,37,2
Pg. 0286-0292

Association between non-dipper hypertension and vitamin D deficiency in women with systemic lupus erythematosus
J. Sabio, J. Vargas-Hitos, J. Martínez-Bordonado, J. Mediavilla-García
Rheumatology ArticleRheumatology Abstract
 

CER11189
2019,37,2
Pg. 0293-0300

Tocilizumab modulates serum levels of adiponectin and chemerin in patients with rheumatoid arthritis: potential cardiovascular protective role of IL-6 inhibition
A. Fioravanti, S. Tenti, M. Bacarelli, A. Damiani, F. Li Gobbi, F. Bandinelli, S. Cheleschi, M. Galeazzi, M. Benucci › Free to View
Rheumatology ArticleRheumatology Abstract
Brief Papers

CER11213
2019,37,2
Pg. 0301-0305

Efficacy of anti-tumour necrosis factor-α monoclonal antibodies in patients with non-infectious anterior uveitis
C. Fabiani, A. Vitale, D. Rigante, G. Emmi, G. Lopalco, J. Sota, L. Vannozzi, S. Guerriero, A. Bitossi, I. Orlando, R. Franceschini, B. Frediani, M. Galeazzi, F. Iannone, G. Tosi, L. Cantarini › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER11387
2019,37,2
Pg. 0306-0309

Fibroblast-like synoviocytes from fluid and synovial membrane from primary osteoarthritis demonstrate similar production of interleukin 6, and metalloproteinases 1 and 3
C. Machado, G. Resende, R. Macedo, V. do Nascimento, A. Branco, A. Kakehasi, M. Andrade
Rheumatology ArticleRheumatology Abstract
Review

CER11129
2019,37,2
Pg. 0310-0317

Clinical implications of peripheral new bone formation in psoriatic arthritis: a literature-based review
A. Marchesoni, R. Caporali, E. Lubrano › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER11253
2019,37,2
Pg. 0318-0323

Tocilizumab and the risk of respiratory adverse events in patients with rheumatoid arthritis: a systematic review and meta-analysis of randomised controlled trials
Z. Geng, Y. Yu, S. Hu, L. Dong, C. Ye › Free to View
Rheumatology Article
Rheumatology Article
Rheumatology Abstract
 

CER11414
2019,37,2
Pg. 0324-0332

Epidemiological characteristics of psoriatic arthritis
M. Migkos, G. Somarakis, T. Markatseli, P. Voulgari, A. Drosos
Rheumatology ArticleRheumatology Abstract
Paediatric Rheumatology

CER11292
2019,37,2
Pg. 0333-0337

Association between STAT4 polymorphisms and the risk of juvenile idiopathic arthritis in Han Chinese populations
X. Huang, Z. Wang, N. Jia, S. Shangguan, J. Lai, X. Cui, F. Wu, L. Wang
Rheumatology Article
Rheumatology Article
Rheumatology Abstract
Letter

CER11371
2019,37,2
Pg. 0338-0339

S100A11 (calgizzarin) is released by circulating mononuclear cells and its elevated plasma levels distinguish systemic lupus erythematosus patients from healthy individuals
L. Cerezo, B. Šumová, H. Hulejová, H. Štorkánová, L. Szczuková, M. Tomčík, R. Bečvář, K. Pavelka, J. Vencovský, J. Závada, L. Šenolt › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER11645
2019,37,2
Pg. 0340-0341

Interstitial lung pathology: should we test for autoantibodies to cellular antigens?
J. Serelis, A. Athanasakos, F. Skopouli, H. Moutsopoulos › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER11633
2019,37,2
Pg. 0342-0343

Real world use of secukinumab for treatment of axial spondyloarthritis and psoriatic arthritis: nationwide results from the ATTRA registry
H. Mann, J. Závada, L. Šenolt, K. Bubová, L. Nekvindová, Z. Křístková, P. Horák, J. Vencovský, K. Pavelka; and the ATTRA Registry › Free to View
Rheumatology ArticleRheumatology Abstract
 

CER11613
2019,37,2
Pg. 0344-0345

Safety of the use of anti-IL17A treatment in a patient with certolizumab-induced sarcoidosis
E. Toussirot, C. Bernard, M. Bossert › Free to View
Rheumatology ArticleRheumatology Abstract
Erratum Corrige

CER12248
2019,37,2
Pg. 0345

Erratum corrige: “Peripheral CD4+CD28null T-cells as predictors of damage in systemic lupus erythematosus patients”. M.F. Ugarte-Gil et al.
M. Ugarte-Gil, C. Sánchez-Zúñiga, R. Gamboa-Cardenas, M. Aliaga-Zamudio, F. Zevallos, A. Mosqueira-Riveros, M. Medina-Chinchón, G. Tineo-Pozo, C. Elera-Fitzcarrald, V. Pimentel-Quiroz, O. Sarmiento-Velasquez, C. Reátegui-Sokolova, J. Cucho-Venegas, J. Alfaro-Lozano, Z. Rodriguez-Bellido, C. Pastor-Asurza, G. Alarcón, R. Perich-Campos › Free to View
Rheumatology ArticleRheumatology Abstract